Cantitate/Preț
Produs
Total produse
Vezi coșul
Precision Medicine in Cancer Therapy de Daniel D. Von Hoff

Precision Medicine in Cancer Therapy: Cancer Treatment and Research, cartea 178

Editat de Daniel D. Von Hoff, Haiyong Han
en Limba Engleză Paperback – 15 aug 2020
This book presents the latest advances in precision medicine in some of the most common cancer types, including hematological, lung and breast malignancies. It also discusses emerging technologies that are making a significant impact on precision medicine in cancer therapy. In addition to describing specific approaches that have already entered clinical practice, the book explores new concepts and tools that are being developed.

Precision medicine aims to deliver personalized healthcare tailored to a patient’s genetics, lifestyle and environment, and cancer therapy is one of the areas in which it has flourished in recent years. Documenting the latest advances, this book is of interest to physicians and clinical fellows in the front line of the war on cancer, as well as to basic scientists working in the fields of cancer biology, drug development, biomarker discovery, and biomedical engineering. The contributing authors include translational physicians withfirst-hand experience in precision patient care.

Citește tot Restrânge

Toate formatele și edițiile

Toate formatele și edițiile Preț Express
Paperback (1) 55636 lei  38-44 zile
  Springer International Publishing – 15 aug 2020 55636 lei  38-44 zile
Hardback (1) 78137 lei  38-44 zile
  Springer International Publishing – 27 iun 2019 78137 lei  38-44 zile

Din seria Cancer Treatment and Research

  • 5% T-Cell and NK-Cell Lymphomas: From Biology to Novel Therapies
    Preț: 108067 lei
  • 5% HIV/AIDS-Associated Viral Oncogenesis
    Preț: 71164 lei
  • 5% Tumor Microenvironment
    Preț: 77165 lei
  • 5% Cancer Immunotherapies: Solid Tumors and Hematologic Malignancies
    Preț: 101690 lei
  • 5% Cancer Drug Safety and Public Health Policy: A Changing Landscape
    Preț: 101174 lei
  • 5% Therapeutic Approaches in Cancer Treatment
    Preț: 102065 lei
  • 5% Targeting the DNA Damage Response for Cancer Therapy
    Preț: 89885 lei
  • 5% Threshold Decision-making in Clinical Medicine: With Practical Application to Hematology and Oncology
    Preț: 70449 lei
  • 5% Epigenetics in Oncology
    Preț: 90154 lei
  • 5% Hodgkin’s Disease in Children: Controversies and Current Practice
    Preț: 47291 lei
  • 5% Molecular Genetics and Therapy of Leukemia
    Preț: 65184 lei
  • 5% Surgical Oncology
    Preț: 49135 lei
  • 5% Adrenal and Endocrine Tumors in Children: Adrenal Cortical Carcinoma and Multiple Endocrine Neoplasia
    Preț: 70662 lei
  • 5% Lung Cancer 1
    Preț: 36294 lei
  • 15% Bayesian Methods in Reliability
    Preț: 68593 lei
  • 5% Gynecologic Oncology
    Preț: 207387 lei
  • 5% Palliative Care and Rehabilitation of Cancer Patients
    Preț: 138539 lei
  • 5% Advances in Allogeneic Hematopoietic Stem Cell Transplantation
    Preț: 139526 lei
  • 5% HIV & HTLV-I Associated Malignancies
    Preț: 108427 lei
  • 5% Thoracic Oncology
    Preț: 127132 lei
  • 5% Cancer Chemoprevention
    Preț: 108088 lei
  • 5% Myelodysplastic Syndromes & Secondary Acute Myelogenous Leukemia: Directions for the New Millennium
    Preț: 107226 lei
  • 5% Liver-Directed Therapy for Primary and Metastatic Liver Tumors
    Preț: 107424 lei
  • 5% Biology and Management of Lung Cancer
    Preț: 138489 lei
  • 5% Non-Myeloablative Allogeneic Transplantation
    Preț: 70554 lei
  • 5% Atlas of Selective Sentinel Lymphadenectomy for Melanoma, Breast Cancer and Colon Cancer
    Preț: 69248 lei
  • 5% Clinically Relevant Resistance in Cancer Chemotherapy
    Preț: 71629 lei
  • 5% Biostatistical Applications in Cancer Research
    Preț: 138609 lei
  • 5% Head and Neck Cancer
    Preț: 108624 lei
  • 5% Signal Transduction in Cancer
    Preț: 107586 lei
  • 5% Kidney Cancer
    Preț: 107010 lei
  • 5% Angiogenesis in Brain Tumors
    Preț: 107727 lei
  • 5% The Biology of Skeletal Metastases
    Preț: 108390 lei

Preț: 55636 lei

Preț vechi: 58565 lei
-5% Nou

Puncte Express: 835
Preț estimativ în valută:
10648€ • 11060$ • 8844£

Carte tipărită la comandă

Livrare economică 29 ianuarie-04 februarie 25

 Adaugă în coș

Wish list
Gift list
Am citit!
Adaugă în listă
Preluare comenzi: 021 569.72.76

Specificații

ISBN-13: 9783030163938
ISBN-10: 3030163938
Pagini: 283
Ilustrații: X, 283 p.
Dimensiuni: 155 x 235 mm
Ediția:1st ed. 2019
Editura: Springer International Publishing
Colecția Springer
Seria Cancer Treatment and Research

Locul publicării:Cham, Switzerland

Cuprins

Part I: Individual types of cancer precision medicine, Hematological malignancies.- Lung cancer.- Breast cancer.- Rare malignancies.- Part II: Currently available techniques, Immunohistochemistry enabled precision medicine.- Genomics enabled precision medicine.- Proteomics enabled precision medicine.-  Metabolomics enabled precision medicine, Part III: Future precision medicine.- Imaging precision medicine.- Single cell sequencing in precision medicine.- Microbiome in precision medicine.- Perspectives on precision medicine.

Notă biografică

Daniel Von Hoff is a physician scientist whose major interest is the development of new anticancer agents, in both clinic and laboratory settings. He played a pivotal role in the development of many of the anticancer agents now being used routinely. He also pioneered the application of genomics profiling in the clinical care of patients with cancer. Dr. Von Hoff is a former member of the FDA’s Oncology Drug Advisory Committee (ODAC) and served on President Bush’s National Cancer Advisory Board. He is a former president of the American Association of Cancer Research (AACR) and a past member of the Board of Scientific Advisors of the National Cancer Institute, as well as a former board member of the American Society of Clinical Oncology (ASCO).

Haiyong Han is a tumor biologist with a major interest in targeted drug discovery.  He has more than 20 years of experience in preclinical drug development for cancers, particularly pancreatic cancer. His major areas of expertise include the identification and validation of drug targets and biomarkers, lead identification and optimization, and preclinical evaluation and development. Dr. Han has published more than 70 peer reviewed articles and was an inventor on 15 patents/patent applications.

Textul de pe ultima copertă

This book presents the latest advances in precision medicine in some of the most common cancer types, including hematological, lung and breast malignancies. It also discusses emerging technologies that are making a significant impact on precision medicine in cancer therapy. In addition to describing specific approaches that have already entered clinical practice, the book explores new concepts and tools that are being developed.

Precision medicine aims to deliver personalized healthcare tailored to a patient’s genetics, lifestyle and environment, and cancer therapy is one of the areas in which it has flourished in recent years. Documenting the latest advances, this book is of interest to physicians and clinical fellows in the front line of the war on cancer, as well as to basic scientists working in the fields of cancer biology, drug development, biomarker discovery, and biomedical engineering. The contributing authors include translational physicians withfirst-hand experience in precision patient care.

Caracteristici

Describes new and emerging technologies that are impacting on precision medicine in cancer therapy Documents advances in precision medicine in some of the most common cancer types Written by renowned experts, including translational physicians with first-hand experience in precision patient care